Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Infectious Disease _ Pharmaceuticals, Biotechnology & Drugs

Microbia

Parents

Applies proprietary knowledge relating to cell circuitry in microbes to discover and develop both better and safer anti-infectiv
Developed a Highly Effective Technology Platform that Enables It to Produce High-quality, Natural Carotenoids (including Β- Carotene and Canthaxanthin), Nutritional Products and Other Specialty Materials and Chemicals from Renewable Resources
Developed a multifaceted metabolic engineering approach that enables more efficient and cost-effective production of pharmaceuti
DSM acquires Microbia, Inc. to expand its leading position in specialty ingredients (2010)
Lexington, Massachusetts
Microbia collaborated with several well-known leaders in their respective markets including DuPont Central Research & Development, Novus International, Tate & Lyle, Ranbaxy Laboratories, and Teva Pharmaceuticals
Our team has developed a novel production platform for "lipophilic chemicals"-fat-loving compounds that currently represent an aggregate commercial opportunity in excess of $2 billion